BioCryst Pharmaceuticals | SCHULD



Debt Veränderung Datum
Alnylam Pharmaceuticals USD 1.03B 945K 2025-03
Chugai Pharma JPY 0 0 2025-03
Daiichi Sankyo JPY 101.33B 97M 2025-03
DBV Technologies USD 0 0 2025-03
Gilead Sciences USD 26.71B 3.46B 2024-12
GlaxoSmithKline GBP 18.43B 1.45B 2025-03
Glaxosmithkline GBP 16.99B 927M 2024-12
Incyte USD 37.12M 840K 2025-03
Ionis Pharmaceuticals USD 1.25B 5.23M 2025-03
Neurocrine Biosciences USD 0 0 2024-12
PTC Therapeutics USD 2.4B 17.29M 2025-03
Regeneron Pharmaceuticals USD 2.7B 400K 2025-03
Roche Holding CHF 34.44B 5.23B 2024-06
Sarepta Therapeutics USD 1.14B 1.16M 2025-03
Ultragenyx Pharmaceutical USD 0 0 2024-12
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12



BioCryst Pharmaceuticals SCHULD - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Jul 2025.